The Unwinding of Circular Deoxyribonucleic Acid by Phenanthridinium Drugs: Structure-Activity Relations for the Intercalation Reaction
The interaction between a series of phenanthridinium drugs and bacteriophage PM2 circular DNA has been studied with the object of investigating how substituents on the phenanthridine chromophore affect its capacity to intercalate between the DNA base pairs. Variations in the quaternising group at po...
Saved in:
Published in | Molecular pharmacology Vol. 10; no. 3; pp. 544 - 561 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.05.1974
American Society for Pharmacology and Experimental Therapeutics |
Subjects | |
Online Access | Get full text |
ISSN | 0026-895X 1521-0111 |
DOI | 10.1016/S0026-895X(25)13944-8 |
Cover
Abstract | The interaction between a series of phenanthridinium drugs and bacteriophage PM2 circular DNA has been studied with the object of investigating how substituents on the phenanthridine chromophore affect its capacity to intercalate between the DNA base pairs. Variations in the quaternising group at position 5 have little or no effect. The presence of a phenyl substituent at position 6 strongly influences external attachment to the DNA helix and affects the unwinding angle. Introduction of a p-carboxyl group on the phenyl ring leads to weaker binding. Free primary amino groups at positions 3 and 8 are not mandatory for the intercalation reaction, but their presence adds stability to the complex (approximately 1.7 kcal/mole). Removal of the 3-amino group has little effect other than a small reduction in the unwinding angle, whereas acetylation of the 8-amino gruop results in weaker binding as well as a lowered unwinding angle. Replacement of both 3- and 8-amino groups by carbethoxyamino substituents leads to markedly weaker binding and an apparent unwinding angle of only 5.1° ± 0.6°, the lowest value observed with any phenanthridine, together with other consequences which suggest a radical alteration in the mechanism of binding to DNA. Introduction of bromine atoms in place of amino groups at positions 3 and 8 yields a heavy-atom derivative which still unwinds the DNA helix by the same angle as ethidium at low ionic strength. Structure-activity correlations for the intercalation reaction deduced from these studies are in agreement with earlier findings relating to antimicrobial activity.
ACKNOWLEDGMENTS We thank and Mr. N. F. Totty for skilled technical assistance, and many colleagues for helpful advice and criticism. We are especially grateful to Drs. R. Slack, S. S. Berg, and G. Woolfe for generous supplies of the drugs, together with precise analytical data on their chemical constitution. |
---|---|
AbstractList | The interaction between a series of phenanthridinium drugs and bacteriophage PM2 circular DNA has been studied with the object of investigating how substituents on the phenanthridine chromophore affect its capacity to intercalate between the DNA base pairs. Variations in the quaternising group at position 5 have little or no effect. The presence of a phenyl substituent at position 6 strongly influences external attachment to the DNA helix and affects the unwinding angle. Introduction of a p-carboxyl group on the phenyl ring leads to weaker binding. Free primary amino groups at positions 3 and 8 are not mandatory for the intercalation reaction, but their presence adds stability to the complex (approximately 1.7 kcal/mole). Removal of the 3-amino group has little effect other than a small reduction in the unwinding angle, whereas acetylation of the 8-amino gruop results in weaker binding as well as a lowered unwinding angle. Replacement of both 3- and 8-amino groups by carbethoxyamino substituents leads to markedly weaker binding and an apparent unwinding angle of only 5.1° ± 0.6°, the lowest value observed with any phenanthridine, together with other consequences which suggest a radical alteration in the mechanism of binding to DNA. Introduction of bromine atoms in place of amino groups at positions 3 and 8 yields a heavy-atom derivative which still unwinds the DNA helix by the same angle as ethidium at low ionic strength. Structure-activity correlations for the intercalation reaction deduced from these studies are in agreement with earlier findings relating to antimicrobial activity.
ACKNOWLEDGMENTS We thank and Mr. N. F. Totty for skilled technical assistance, and many colleagues for helpful advice and criticism. We are especially grateful to Drs. R. Slack, S. S. Berg, and G. Woolfe for generous supplies of the drugs, together with precise analytical data on their chemical constitution. The interaction between a series of phenanthridinium drugs and bacteriophage PM2 circular DNA has been studied with the object of investigating how substituents on the phenanthridine chromophore affect its capacity to intercalate between the DNA base pairs. Variations in the quaternising group at position 5 have little or no effect. The presence of a phenyl substituent at position 6 strongly influences external attachment to the DNA helix and affects the unwinding angle. Introduction of a p -carboxyl group on the phenyl ring leads to weaker binding. Free primary amino groups at positions 3 and 8 are not mandatory for the intercalation reaction, but their presence adds stability to the complex (approximately 1.7 kcal/mole). Removal of the 3-amino group has little effect other than a small reduction in the unwinding angle, whereas acetylation of the 8-amino gruop results in weaker binding as well as a lowered unwinding angle. Replacement of both 3- and 8-amino groups by carbethoxyamino substituents leads to markedly weaker binding and an apparent unwinding angle of only 5.1° ± 0.6°, the lowest value observed with any phenanthridine, together with other consequences which suggest a radical alteration in the mechanism of binding to DNA. Introduction of bromine atoms in place of amino groups at positions 3 and 8 yields a heavy-atom derivative which still unwinds the DNA helix by the same angle as ethidium at low ionic strength. Structure-activity correlations for the intercalation reaction deduced from these studies are in agreement with earlier findings relating to antimicrobial activity. |
Author | WAKELIN, L.P.G. WARING, M.J. |
Author_xml | – sequence: 1 givenname: L.P.G. surname: WAKELIN fullname: WAKELIN, L.P.G. – sequence: 2 givenname: M.J. surname: WARING fullname: WARING, M.J. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/4859556$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkcFu1DAQhi1UVLaFR6jkCwgOKXZiex04oNUWSqVKINpK3CzHmWyMsvZiOy37Ajw33s3CgUtPtub_vxnN_CfoyHkHCJ1Rck4JFW9vCClFIWv-_XXJ39CqZqyQT9CM8pIWhFJ6hGb_LM_QSYw_CKGMS3KMjpnkNedihn7f9oDv3IN1rXUr7Du8tMGMgw74AvyvbbCNd6MZwBq8MLbFzRZ_7cFpl_pgM2PHNb4I4yq-wzcpjCaNAYqFSfbepi3-BoNO1ruIOx9wyrOuXIJg9FTOuja7z3P0tNNDhBeH9xTdffp4u_xcXH-5vFourgtTEZ6KuezKRlRA2Jw1nJOy1mUNuiJMCMGA1wRk11LZ1G3XgZZsXlWM5KKci5ZXVXWKXk19N8H_HCEmtbbRwDBoB36MSpa8rAUX2Xh2MI7NGlq1CXatw1YdDpf195Nugo8xQKeMTfudUtB2UJSoXUpqn5LaRaBKrvYpKZlp_h_9t_9j3MuJ6-2qf7AB1KbXYa2NH_xqD1eKM5Z9HyYf5FveWwgqGgvOQJsZk1Tr7SOT_gCUE7kG |
CitedBy_id | crossref_primary_10_1002_chem_200902823 crossref_primary_10_1016_0360_3016_92_90871_E crossref_primary_10_1002_qua_560160716 crossref_primary_10_1111_j_2042_7158_1976_tb04122_x |
ContentType | Journal Article |
Copyright | 1974 American Society for Pharmacology and Experimental Therapeutics |
Copyright_xml | – notice: 1974 American Society for Pharmacology and Experimental Therapeutics |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/S0026-895X(25)13944-8 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology Chemistry |
EISSN | 1521-0111 |
EndPage | 561 |
ExternalDocumentID | 4859556 10_1016_S0026_895X_25_13944_8 10_3_544 S0026895X25139448 |
Genre | Journal Article |
GroupedDBID | --- -~X .55 .GJ 0R~ 123 18M 2WC 34G 39C 4.4 53G 5RE 5VS AAJMC AALRI AAXUO ABCQX ABJNI ABSQV ACGFO ACGFS ADBBV ADCOW AENEX AERNN AFFNX AFHIN AFOSN ALMA_UNASSIGNED_HOLDINGS AYCSE BAWUL BTFSW CS3 DIK E3Z EBS EJD F5P F9R FDB GX1 H13 HH5 HZ~ IH2 INIJC K-O KQ8 L7B LSO M41 MVM N9A O9- OK1 P2P R.V R0Z RHF RHI ROL RPT TR2 UQL W8F WOQ X7M XOL YBU YHG ZGI ZXP - 08R 0R 55 AALRV AAPBV ABFLS ABSGY ABZEH ADBIT DL FH7 GJ HZ X ZA5 AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c305t-78f2b63e0474b55029a29ea3046664e590e8fd18b9dffea84733400e8876d5333 |
ISSN | 0026-895X |
IngestDate | Fri Sep 05 11:21:51 EDT 2025 Tue Aug 05 11:39:52 EDT 2025 Thu Apr 24 23:02:10 EDT 2025 Tue Jul 01 05:36:05 EDT 2025 Tue Jan 05 21:16:52 EST 2021 Sat Feb 08 15:52:06 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c305t-78f2b63e0474b55029a29ea3046664e590e8fd18b9dffea84733400e8876d5333 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 4859556 |
PQID | 82529656 |
PQPubID | 23479 |
PageCount | 18 |
ParticipantIDs | proquest_miscellaneous_82529656 pubmed_primary_4859556 crossref_citationtrail_10_1016_S0026_895X_25_13944_8 crossref_primary_10_1016_S0026_895X_25_13944_8 highwire_pharmacology_10_3_544 elsevier_sciencedirect_doi_10_1016_S0026_895X_25_13944_8 |
ProviderPackageCode | RHF RHI CITATION AAYXX |
PublicationCentury | 1900 |
PublicationDate | 1974-May |
PublicationDateYYYYMMDD | 1974-05-01 |
PublicationDate_xml | – month: 05 year: 1974 text: 1974-May |
PublicationDecade | 1970 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Molecular pharmacology |
PublicationTitleAlternate | Mol Pharmacol |
PublicationYear | 1974 |
Publisher | Elsevier Inc American Society for Pharmacology and Experimental Therapeutics |
Publisher_xml | – name: Elsevier Inc – name: American Society for Pharmacology and Experimental Therapeutics |
SSID | ssj0014580 |
Score | 1.2900113 |
Snippet | The interaction between a series of phenanthridinium drugs and bacteriophage PM2 circular DNA has been studied with the object of investigating how... The interaction between a series of phenanthridinium drugs and bacteriophage PM2 circular DNA has been studied with the object of investigating how... |
SourceID | proquest pubmed crossref highwire elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 544 |
SubjectTerms | Amines Animals Bacteriophages Bromine Buffers Cattle Chemical Phenomena Chemistry Dialysis Dimethyl Sulfoxide DNA, Circular Ethidium - pharmacology Phenanthridines - pharmacology Spectrophotometry, Ultraviolet Structure-Activity Relationship Thymus Gland Ultracentrifugation |
Title | The Unwinding of Circular Deoxyribonucleic Acid by Phenanthridinium Drugs: Structure-Activity Relations for the Intercalation Reaction |
URI | https://dx.doi.org/10.1016/S0026-895X(25)13944-8 http://molpharm.aspetjournals.org/content/10/3/544.abstract https://www.ncbi.nlm.nih.gov/pubmed/4859556 https://www.proquest.com/docview/82529656 |
Volume | 10 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLVgvPCCxsdE-Rh-YBOoS0gcO3F4q9hgbCsqWyv1zYpTl0Ua6dS1gvID-N1c20ncbkyDvURRYjuRzrF9r33PNUKvOU31wdWxlwOZPMoD6nGd9DMD0z7kIx4msdYOd7_E-wN6MGRDt11g1CUz6ee__qoruQ2q8Axw1SrZ_0C2aRQewD3gC1dAGK7_jPGg_FFYZYoOrCimNq50V01-LqaFnJQ6X3GRtzt5YUzN3qnSoS-n0wLqFPPv7d3p_JsJizsxmWTnU-V18upICRcpVwcjmgVEgNXS5lhZWcSyhdutz9ttn7us2G7dvnO4d_TZhBYc-T3_k-9eHFfyqa5_4Lu1iBA8ERf5ZxfIapHMSgyndvOAAGy4MugGS-SKlkZQZtNBVpMxs5nar4zzdsnhpGl6S0twt4jOcUqpx93k1oQcmrK6KBh0uhC_i-6RJDFb-4df3c4TZdzKlqqWnerrnfvcG8LeVp-6zp5p0k1f77oYE6a_jh5UvgfuWCI9RHdU-Qht9yxMix3cd1q8ix28jXtLAD5Gv-E1btiGJ2Ncsw1fZhvWbMNygS-zDRu2vcdXuYYbrmHgGgau4RWu4ZprT9Dg417_w75XneJhuv_MS_iYyDhSAU2oBH-YpBlJVaZ35OOYKpYGio9HIZfpaDxWGVhLUQQTi4LZLx6BMxJtoLVyUqqnCDNFooRENFZaEZ3LNMhCxuVIZiqF6qSFaI2FyKsU9_qklTPhYhkBQqEhFIQJA6HgLeQ31c5tjpebKvAaaFEZqtYAFcDPm6pu1sQQy91Q14oEkL-FXtV0ETDS6-27rFST-YUAhpMU3K8W2rAsan6W6iSFLH52-996ju67_vwCrQEL1Euwtmdy03SPPxddz54 |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Unwinding+of+Circular+Deoxyribonucleic+Acid+by+Phenanthridinium+Drugs%3A+Structure-Activity+Relations+for+the+Intercalation+Reaction&rft.jtitle=Molecular+pharmacology&rft.au=WAKELIN%2C+L.P.G.&rft.au=WARING%2C+M.J.&rft.date=1974-05-01&rft.pub=Elsevier+Inc&rft.issn=0026-895X&rft.volume=10&rft.issue=3&rft.spage=544&rft.epage=561&rft_id=info:doi/10.1016%2FS0026-895X%2825%2913944-8&rft.externalDocID=S0026895X25139448 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0026-895X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0026-895X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0026-895X&client=summon |